Back

State-of-the-art lecture in the role of bleeding in determining DAPT .

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

1 More presentation in this session

Presentation thumbnail
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome
Doctor J. Tjerkaski (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
The role of bleeding in determining antithrombotic treatment in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
DAPT, monotherapy, or more? Rethinking antithrombotic strategies after percutaneous coronary intervention
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
thumbnail
Congress Presentation
Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources